Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Healthcare (Basel) ; 10(1)2022 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-35052305

RESUMO

(1) Background: Visual impairment of people with diabetic retinopathy (DR) and its high impact on different dimensions of their lives can cause a significant deterioration in the quality of life. The aim of this study was to examine the association and relationship between quality of life related to vision and the relevant clinical and sociodemographic variables in a group of patients with DR in Spain. (2) Methods: A descriptive cross-sectional study was conducted in all patients with DR over 18 years under follow-up in the Retina Service of the University Hospital of Burgos (HUBU), recruited during the months of January and February 2020. The main study variable was quality of life related to health and vision, obtained using the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25). (3) Results: In total 87 participants made up the sample, and significant differences were found in the NEI-VFQ-25 according to gender, type of diabetes, episodes of decompensated diabetes and high blood pressure (HBP) (p < 0.05). Best-corrected visual acuity (BCVA) was also correlated with the NEI-VFQ-25 (p < 0.05). (4) Conclusions: These data could facilitate the design of action protocols focused on the well-being of the patient, in addition to considering the clinical characteristics. Further studies are needed to help understand the causal relationship between variables and that includes a wider variety of factors.

2.
Emergencias ; 30(1): 14-20, 2018 02.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29437305

RESUMO

OBJECTIVES: To determine whether the adjustment of antidiabetic treatment of patients discharged from a short-stay unit (SSU) after a hyperglycemic crisis reduces the rate of adverse events in the next 90 days. MATERIAL AND METHODS: Retrospective study of patients admitted to an emergency SSU in June 2011. We gathered information on patient demographics, concurrent diseases, reason for admission, and appropriateness of antidiabetic treatment on discharge. Patients were classified as diabetic, nondiabetic, or newly hyperglycemic. Patients with altered carbohydrate metabolism were subclassified according to the appropriateness of the antidiabetic treatment prescribed on discharge. The main outcome variable was the occurrence of an adverse event within 90 days of discharge. RESULTS: We included 750 patients with a mean (SD) age of 68.1 (19.5) years; 357 (47.6%) were men. A new adverse event occurred in 262 (36%) patients within 90 days; 15.6 (31.5%) of these patients were not diabetic, 77 (41.8%) were diabetic, and 29 (59.2%) were newly hyperglycemic (P<.001). Failure to provide an appropriate antidiabetic regimen when discharging patients with altered carbohydrate metabolism was an independent risk factor for an adverse event within 90 days (adjusted odds ratio, 7.2; 95% CI, 3.9­13.3). CONCLUSION: Lack of appropriate antidiabetic treatment after discharge from an emergency SSU is a risk factor for adverse events within 90 days.


OBJETIVO: Determinar si el adecuado tratamiento al alta de la hiperglucemia en pacientes atendidos en una unidad de corta estancia (UCE) es un factor relacionado con la reducción de eventos adversos a tres meses tras el alta. METODO: Estudio de cohorte retrospectivo que incluyó los pacientes ingresados en una UCE durante el mes de junio de 2011. Se incluyeron variables demográficas, comorbilidad, causa de ingreso y congruencia del tratamiento antidiabético al alta. Se clasificó a los pacientes en diabéticos, no diabéticos y nuevos hiperglucémicos (NHG), y en aquellos con alteración del metabolismo hidrocarbonado, la variable clasificadora fue la congruencia del tratamiento antidiabético al alta. La variable de resultado principal fue la aparición de un evento adverso compuesto en los tres primeros meses tras el alta. RESULTADOS: Se incluyeron 750 pacientes con edad media de 68,1 años (DE 19,5), de los cuales 357 (47,6%) fueron varones, 262 (36%) pacientes sufrieron un evento adverso a los 3 meses. De ellos, 156 (31,5%) fueron no diabéticos, 77 (41,8%) diabéticos y 29 (59,2%) NHG (p < 0,001). En los pacientes con alteración hidrocarbonada, el tener un tratamiento antidiabético no congruente al alta de una UCE fue un factor de riesgo independiente de sufrir un eventoadverso a 3 meses del alta [OR ajustada 7,2 (IC 95%: 3,9-13,3)]. CONCLUSIONES: Un tratamiento antidiabético no adecuado al alta de una UCE se muestra como un factor independiente de sufrir un evento adverso en los tres primeros meses.


Assuntos
Diabetes Mellitus/tratamento farmacológico , Serviço Hospitalar de Emergência , Hipoglicemiantes/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Hiperglicemia/tratamento farmacológico , Hiperglicemia/prevenção & controle , Hipoglicemiantes/uso terapêutico , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Alta do Paciente , Readmissão do Paciente , Recidiva , Estudos Retrospectivos , Espanha
3.
Emergencias (St. Vicenç dels Horts) ; 30(1): 14-20, feb. 2018. tab, graf, ilus
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-169890

RESUMO

Objetivo. Determinar si el adecuado tratamiento al alta de la hiperglucemia en pacientes atendidos en una unidad de corta estancia (UCE) es un factor relacionado con la reducción de eventos adversos a tres meses tras el alta. Método. Estudio de cohorte retrospectivo que incluyó los pacientes ingresados en una UCE durante el mes de junio de 2011. Se incluyeron variables demográficas, comorbilidad, causa de ingreso y congruencia del tratamiento antidiabético al alta. Se clasificó a los pacientes en diabéticos, no diabéticos y nuevos hiperglucémicos (NHG), y en aquellos con alteración del metabolismo hidrocarbonado, la variable clasificadora fue la congruencia del tratamiento antidiabético al alta. La variable de resultado principal fue la aparición de un evento adverso compuesto en los tres primeros meses tras el alta. Resultados. Se incluyeron 750 pacientes con edad media de 68,1 años (DE 19,5), de los cuales 357 (47,6%) fueron varones, 262 (36%) pacientes sufrieron un evento adverso a los 3 meses. De ellos, 156 (31,5%) fueron no diabéticos, 77 (41,8%) diabéticos y 29 (59,2%) NHG (p < 0,001). En los pacientes con alteración hidrocarbonada, el tener un tratamiento antidiabético no congruente al alta de una UCE fue un factor de riesgo independiente de sufrir un evento adverso a 3 meses del alta [OR ajustada 7,2 (IC 95%: 3,9-13,3)]. Conclusiones. Un tratamiento antidiabético no adecuado al alta de una UCE se muestra como un factor independiente de sufrir un evento adverso en los tres primeros meses (AU)


Objective. To determine whether the adjustment of antidiabetic treatment of patients discharged from a short-stay unit (SSU) after a hyperglycemic crisis reduces the rate of adverse events in the next 90 days. Methods. Retrospective study of patients admitted to an emergency SSU in June 2011. We gathered information on patient demographics, concurrent diseases, reason for admission, and appropriateness of antidiabetic treatment on discharge. Patients were classified as diabetic, nondiabetic, or newly hyperglycemic. Patients with altered carbohydrate metabolism were subclassified according to the appropriateness of the antidiabetic treatment prescribed on discharge. The main outcome variable was the occurrence of an adverse event within 90 days of discharge. Results. We included 750 patients with a mean (SD) age of 68.1 (19.5) years; 357 (47.6%) were men. A new adverse event occurred in 262 (36%) patients within 90 days; 15.6 (31.5%) of these patients were not diabetic, 77 (41.8%) were diabetic, and 29 (59.2%) were newly hyperglycemic (P<.001). Failure to provide an appropriate antidiabetic regimen when discharging patients with altered carbohydrate metabolism was an independent risk factor for an adverse event within 90 days (adjusted odds ratio, 7.2; 95% CI, 3.9-13.3). Conclusion. Lack of appropriate antidiabetic treatment after discharge from an emergency SSU is a risk factor for adverse events within 90 days (AU)


Assuntos
Humanos , Pessoa de Meia-Idade , Idoso , Hiperglicemia/tratamento farmacológico , Diabetes Mellitus/tratamento farmacológico , Efeitos Adversos de Longa Duração/epidemiologia , Fatores de Risco , Hipoglicemiantes/uso terapêutico , Tempo de Internação/tendências , 28599
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA